Conference abstractPublished 7 Dec 2015
Differential serum levels of ubiquitin C-terminal hydrolase-L1 between patients with or without white matter lesions
Dalian Medical University, P R China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ubiquitin Carboxy-Terminal Hydrolase-L1 (UCH-L1) has been established as a reliable and potential biomarker of neuronal damage. There is not much information about the effects of White Matter Lesions (WMLs) on serum UCH-L1 levels in white matter disease patients. This study was aimed to assess whether serum UCH-L1 levels are a reliable marker of brain damage in patients with WMLs. Serum levels of UCH-L1 were assessed by sandwich Enzyme-Linked Immunosorbent Assay (ELISA) in 74 patients with type 2 diabetes mellitus, depression, or vascular disease. MRI was performed by a neuro-radiologist blinded to clinical data. Of these 74 patient cases, 26 showed periventricular WMLs, 22 showed subcortical WMLs, and 26 displayed no well-defined WMLs (controls). Serum UCH-L1 levels were significantly different between the two groups (p<0.05). Further sub-group analysis proved that serum UCH-L1 levels in participants with sub-cortical WMLs were significantly increased when compared with controls (p<0.001), but there was no significant differences between controls and patients with periventricular WMLs (p>0.05). These findings suggest that serum UCH-L1 levels may serve as a novel biomarker for neuronal damage from WMLs, especially sub-cortical WMLs.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Yuyuan Li”